Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Experimental Hematology

• Publication date

  2002-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0301-472X(02)00811-1PMID 12135676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The cellular pathogenesis of paroxysmal nocturnal haemoglobinuria

  2001cited by this paper
• Regulation of Fas Ligand-Induced Apoptosis by TNF1

  2001cited by this paper
• Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol‐anchored protein‐deficient clones

  2001cited by this paper
• Genetics of PNH

  2000cited by this paper
• PNH cells are as sensitive to T-cell-mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria.

  2000cited by this paper
• IMPLICATIONS OF RECENT INSIGHTS INTO THE PATHOPHYSIOLOGY OF PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA

  2000cited by this paper
• PNH cells are as sensitive to T‐cell‐mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria

  2000cited by this paper
• Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria.

  2000cited by this paper
• Synthesis of the GPI Anchor

  2000cited by this paper
• Animal Models of PNH

  2000cited by this paper
• Hemolysis in PNH

  2000cited by this paper
• A Brief History of PNH

  2000cited by this paper
• Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.

  2000cited by this paper
• Cytotoxicity against lymphoblastoid cells mediated by a T‐cell clone from an aplastic anaemia patient: role of CD59 on target cells

  1999cited by this paper
• Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure Syndromes

  1999cited by this paper
• High Incidence of Transiently Appearing Complement-Sensitive Bone Marrow Precursor Cells in Patients with Severe Aplastic Anemia - A Possible Role of High Endogenous IL-2 in Their Suppression

  1999cited by this paper
• The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria.

  1998cited by this paper
• Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis.

  1998cited by this paper
• The PIG-A Mutation and Absence of Glycosylphosphatidylinositol-Linked Proteins Do Not Confer Resistance to Apoptosis in Paroxysmal Nocturnal Hemoglobinuria

  1998cited by this paper
• Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome.

  1997cited by this paper
• The pathophysiology of acquired aplastic anemia.

  1997cited by this paper
• Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.

  1997cited by this paper
• Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.

  1997cited by this paper
• Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.

  1997cited by this paper
• Role of Fas-mediated cell death in the regulation of immune responses.

  1996cited by this paper
• Cyclosporin-responsive pancytopenia and HLA class II alleles of a patient with paroxysmal nocturnal hemoglobinuria.

  1996cited by this paper
• Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.

  1996cited by this paper
• Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice.

  1996cited by this paper
• A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins.

  1996cited by this paper
• The Fas death factor

  1995cited by this paper
• Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG‐A gene.

  1994cited by this paper
• Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.

  1993cited by this paper
• Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria

  1993cited by this paper
• Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59.

  1992cited by this paper
• The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated.

  1992cited by this paper
• Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells.

  1992cited by this paper
• Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.

  1990cited by this paper
• Biosynthesis and function of LFA-3 in human mutant cells deficient in phosphatidylinositol-anchored proteins.

  1988cited by this paper
• Two populations of erythroid cell progenitors in paroxysmal nocturnal hemoglobinuria.

  1984cited by this paper
• Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis.

  1982cited by this paper
• Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis.

  1982cited by this paper

• Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment

  2023cites this paper
• Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria

  2022cites this paper
• Autoimmune Processes as an Important Parameter for the Pathogenesis of Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

  2018cites this paper
• Pathogenesis of Clonal Dominance in PNH: Selection Mechanisms in PNH

  2017cites this paper
• Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria

  2016cites this paper
• Paroxysmal nocturnal hemoglobinuria with rise of blast cells in bone marrow : a case report and review of the literature

  2016cites this paper
• The pathophysiology of paroxysmal nocturnal haemoglobinuria

  2014cites this paper
• Current concepts in the pathophysiology and treatment of aplastic anemia.

  2013cites this paper
• Bone marrow histology in patients with a paroxysmal nocturnal hemoglobinuria clone correlated with clinical parameters

  2013cites this paper
• A new hint to clonal dominance in PNH.

  2012cites this paper
• Mechanism of paroxysmal nocturnal hemoglobinuria clonal dominance: possible roles of different apoptosis and CD8+ lymphocytes in the selection of paroxysmal nocturnal hemoglobinuria clones.

  2012cites this paper
• GPI‐anchored protein‐deficient T cells in patients with aplastic anemia and low‐risk myelodysplastic syndrome: implications for the immunopathophysiology of bone marrow failure

  2011cites this paper
• Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells

  2010cites this paper
• Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria

  2010cites this paper
• De novo “Classic” Paroxysmal Nocturnal Hemoglobinuria (PNH) (Marchiafava-Micheli Syndrome)

  2010cites this paper
• Untersuchung zur Telomerbiologie hämatopoetischer Zellen in Patienten mit Paroxysmaler Nächtlicher Hämoglobinurie (PNH) mittels Proaerolysin multi-color flow-FISH

  2009cites this paper
• NKG2D‐mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes

  2009cites this paper
• The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients.

  2009cites this paper
• How do PIG-A mutant paroxysmal nocturnal hemoglobinuria stem cells achieve clonal dominance?

  2009cites this paper
• Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuria.

  2009cites this paper
• Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.

  2009cites this paper
• Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor‐deficient PIG‐A mutant cells

  2008cites this paper
• Paroxysmal nocturnal hemoglobinuria: stem cells and clonality.

  2008cites this paper
• Telomere length in paroxysmal nocturnal hemoglobinuria correlates with clone size.

  2007cites this paper
• New Insights into Molecular Pathogenesis of Bone Marrow Failure in Paroxysmal Nocturnal Hemoglobinuria

  2007cites this paper
• Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes

  2007cites this paper
• Autoimmunity and malignancy in hematology--more than an association.

  2007cites this paper
• Pathophysiologic mechanisms in acquired aplastic anemia.

  2006cites this paper
• Current concepts in the pathophysiology and treatment of aplastic anemia.

  2006cites this paper
• Immune Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria

  2006cites this paper
• Flow cytometric analysis of CD 55 and CD 59 expression on blood cells in paroxysmal nocturnal haemoglobinuria

  2005cites this paper
• Senescence of Hematopoietic Stem Cells and Bone Marrow Failure

  2005cites this paper
• Myelodysplastic Syndromes: Immunologic mechanisms and treatment of myelodysplastic syndromes

  2005cites this paper
• Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in ‘normal’ phenotype cells

  2005cites this paper
• Flow cytometric analysis of CD55 and CD59 expression on blood cells in paroxysmal nocturnal haemoglobinuria.

  2005cites this paper
• Mean fluorescence intensity rate is a useful marker in the detection of paroxysmal nocturnal hemoglobinuria clones

  2005cites this paper
• Senescence and functional failure in hematopoietic stem cells.

  2004cites this paper
• Increased resistance of PIG-A-bone marrow progenitors to tumor necrosis factor α a and interferon γ g : possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones

  2004cites this paper
• Frequent HPRT mutations in paroxysmal nocturnal haemoglobinuria reflect T cell clonal expansion, not genomic instability

  2004cites this paper
• Production of interferon‐γ by lymphocytes from paroxysmal nocturnal haemoglobinuria patients: relationship with clinical status

  2004cites this paper
• Síndromes de falla medular.

  2004cites this paper
• Increased resistance of PIG-A- bone marrow progenitors to tumor necrosis factor a and interferon gamma: possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones.

  2004cites this paper
• Hematopoietic stem cells in aplastic anemia.

  2003cites this paper
• Stem cells in paroxysmal nocturnal haemoglobinuria and aplastic anaemia: increasing evidence for overlap of haemopoietic defect

  2003influential citation
• Differential apoptosis and Fas expression on GPI‐negative and GPI‐positive stem cells: a mechanism for the evolution of paroxysmal nocturnal haemoglobinuria *

  2003cites this paper
• Effect of proinflammatory cytokines on PIGA- hematopoiesis.

  2003cites this paper
• Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.

  2003cites this paper
• Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually occur in haematopoietic cells that are glycosylphosphatidylinositol‐anchored protein (GPI‐AP) positive

  2003cites this paper
• The relationship of aplastic anemia and PNH

  2002cites this paper
• Acquired Aplastic Anemia

  2002cites this paper